Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Resistance to protease inhibitors

In: Antiretroviral Resistance in Clinical Practice. London: Mediscript; 2006. Chapter 3.
Free Books & Documents
Review

Resistance to protease inhibitors

Noortje van Maarseveen et al.
Free Books & Documents

Excerpt

HIV-1 produces most of its viral proteins as large precursor proteins (Figure 1), including the Gag and the GagPol precursor proteins. The Gag precursor encodes the structural proteins of the virus, whereas GagPol encodes the three viral enzymes protease, reverse transcriptase (RT) and integrase. HIV-1 protease is responsible for the cleavage of these two precursor proteins at a number of different cleavage sites in a defined order, which results in the formation of mature infectious virus particles [–3].

The HIV-1 protease enzyme is a homodimeric enzyme comprising two identical symmetrical subunits of 99 amino acids (Figure 2a). In the middle of the enzyme, there is a cavity that forms the substrate-binding cleft and the active site of the enzyme lies at the bottom of the cleft. The top of the cleft is covered by two mobile flaps, which allow the substrate to enter or leave the cleft.

PubMed Disclaimer

References

    1. Erickson-Viitanen S, Manfredi J, Viitanen P et al. Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease. AIDS Res Hum Retroviruses. 1989;5:577–591. - PubMed
    1. Pettit SC, Moody MD, Wehbie RS et al. The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. J Virol. 1994;68:8017–8027. - PMC - PubMed
    1. Wiegers K, Rutter G, Kottler H et al. Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites. J Virol. 1998;72:2846–2854. - PMC - PubMed
    1. Condra JH, Schleif WA, Blahy OM et al. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature. 1995;374:569–571. - PubMed
    1. Kaplan AH, Michael SF, Wehbie RS et al. Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease. Proc Natl Acad Sci U S A. 1994;91:5597–5601. - PMC - PubMed

LinkOut - more resources